Dornbierer D

Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Switzerland.

6 papers · 2 preprints · ORCID

ArticleAyahuasca

N,N-Dimethyltryptamine and harmine formulation alters transient EEG topography sequences near the peak of the psychedelic state.

Niedernhuber M, Suay D, Lenggenhager B +4

Europe PMC2026
ArticleDMT

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.

Aicher HD, Dornbierer J, Caflisch L +6

Europe PMC2026
ArticlePsilocybin

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [<sup>18</sup>F]FDG-PET study.

Egger K, Bozsak R, Aicher HD +9

Europe PMC2026
PreprintAyahuasca

N, N-Dimethyltryptamine and harmine formulation shifts metastable topography sequences in the cortex

Niedernhuber M, Suay D, Mueller M +3

Europe PMC2025
PreprintPsilocybin

Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study

Egger K, Bozsak R, Aicher H +8

Europe PMC2025
ArticlePsilocybin

Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.

Singer B, Meling D, Hirsch-Hoffmann M +7

Europe PMC2024
ArticleDMT

A pilot study of cerebral metabolism and serotonin 5-HT<sub>2A</sub> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Egger K, Gudmundsen F, Jessen NS +10

Europe PMC2023
ArticlePsilocybin

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Cumming P, Scheidegger M, Dornbierer D +3

Europe PMC2021